Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)

OBJECTIVE: To describe long-term outcomes of patients treated with nivolumab for advanced non-small cell lung cancer (aNSCLC) in everyday clinical practice in France, with a focus on patients aged ⩾80 years, patients with renal impairment and patients with brain metastases. METHODS: The study includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Assié, Jean-Baptiste, Corre, Romain, Levra, Matteo Giaj, Calvet, Christophe Yannick, Gaudin, Anne-Françoise, Grumberg, Valentine, Jouaneton, Baptiste, Cotté, François-Emery, Chouaïd, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745546/
https://www.ncbi.nlm.nih.gov/pubmed/33403011
http://dx.doi.org/10.1177/1758835920967237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745546/
https://www.ncbi.nlm.nih.gov/pubmed/33403011
http://dx.doi.org/10.1177/1758835920967237

Ejemplares similares